お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
982343

神経痛治療の世界市場:治療タイプ、症状、流通チャネル別の予測(2025年まで)およびCOVID-19の累積的影響

Neuralgia Treatment Market Research Report by Treatment Type, by Indication, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
神経痛治療の世界市場:治療タイプ、症状、流通チャネル別の予測(2025年まで)およびCOVID-19の累積的影響
出版日: 2021年02月04日
発行: 360iResearch LLP
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経痛治療の市場規模は、2020年の7億5,890万米ドル(6億6,541万ユーロ)から、2025年末までに11.38%の複合年間成長率(CAGR)で拡大し、13億131万米ドル(11億4,101ユーロ)に逹すると予想されています。

当レポートは、世界の神経痛治療市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の影響、治療タイプ・症状・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査方法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査機器
    • 収集:データソース
    • 分析:データ解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画の作成
    • 実行:調査の実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 症状別市場の見通し
  • 流通チャネル別市場の見通し
  • 治療タイプ別市場の見通し
  • 地域別市場の見通し
  • 競合他社の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響
  • 地理的な成長機会

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 治療タイプ別の世界の神経痛治療市場

  • イントロダクション
  • 薬物ベース
    • 抗けいれん薬
    • 三環系抗うつ薬
  • 外科処置
    • バルーン圧縮
    • グリセロール注射
    • 微小血管減圧術
    • 高周波熱凝固法
    • 定位放射線治療

第7章 症状別市場

  • イントロダクション
  • 糖尿病性ニューロパチー
  • 肋間神経痛
  • 後頭神経痛
  • 末梢神経痛
  • 帯状疱疹後神経痛
  • 三叉神経痛

第8章 流通チャネル別市場

  • イントロダクション
  • ドラッグストア
  • 病院薬局
  • オンライン薬局
  • 小売薬局

第9章 南北アメリカ市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第13章 企業プロファイル

  • Biogen Inc.
  • Cadila Healthcare Limited
  • Cephalon Inc.
  • GlaxoSmithKline PLC
  • GLENMARK PHARMS LTD.
  • H. Lundbeck A/S
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • LGM Pharma LLC
  • Lupin Limited
  • Novartis AG
  • Pfizer Inc.
  • Psychotropics India Limited
  • 武田薬品工業
  • Teikoku Pharma USA, Inc.
  • Teva Pharmaceuticals Ltd.
  • Torrent Pharmaceuticals Ltd.
  • UCB Group

第14章 付録

  • 考察ガイド
図表

List of Figures

  • FIGURE 1. GLOBAL NEURALGIA TREATMENT MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEURALGIA TREATMENT MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 12. GLOBAL NEURALGIA TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 13. GLOBAL NEURALGIA TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2025 (%)
  • FIGURE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025
  • FIGURE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG BASED, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
  • FIGURE 27. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025
  • FIGURE 29. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, 2020 VS 2025 (USD MILLION)
  • FIGURE 33. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2020 VS 2025 (USD MILLION)
  • FIGURE 35. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
  • FIGURE 36. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
  • FIGURE 38. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2020 VS 2025 (USD MILLION)
  • FIGURE 40. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2020 VS 2025 (USD MILLION)
  • FIGURE 41. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2020 VS 2025 (USD MILLION)
  • FIGURE 42. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 43. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 45. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. CANADA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 51. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 53. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. CHINA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. INDIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 65. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. ITALY NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. QATAR NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 74. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 75. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. GLOBAL NEURALGIA TREATMENT MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 77. GLOBAL NEURALGIA TREATMENT MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 78. GLOBAL NEURALGIA TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEURALGIA TREATMENT MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG BASED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. CHINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. CHINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. INDIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. INDIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. QATAR NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. GLOBAL NEURALGIA TREATMENT MARKET: SCORES
  • TABLE 114. GLOBAL NEURALGIA TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 115. GLOBAL NEURALGIA TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 116. GLOBAL NEURALGIA TREATMENT MARKET: RANKING
  • TABLE 117. GLOBAL NEURALGIA TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 118. GLOBAL NEURALGIA TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 119. GLOBAL NEURALGIA TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 120. GLOBAL NEURALGIA TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 121. GLOBAL NEURALGIA TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 122. GLOBAL NEURALGIA TREATMENT MARKET: LICENSE & PRICING
目次
Product Code: MRR-50AD649

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Neuralgia Treatment Market is expected to grow from USD 758.90 Million in 2020 to USD 1,301.31 Million by the end of 2025.

2. The Global Neuralgia Treatment Market is expected to grow from EUR 665.41 Million in 2020 to EUR 1,141.01 Million by the end of 2025.

3. The Global Neuralgia Treatment Market is expected to grow from GBP 591.55 Million in 2020 to GBP 1,014.36 Million by the end of 2025.

4. The Global Neuralgia Treatment Market is expected to grow from JPY 80,993.86 Million in 2020 to JPY 138,882.75 Million by the end of 2025.

5. The Global Neuralgia Treatment Market is expected to grow from AUD 1,102.02 Million in 2020 to AUD 1,889.67 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Neuralgia Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment Type, the Neuralgia Treatment Market studied across Drug Based and Surgery. The Drug Based further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery.

Based on Indication, the Neuralgia Treatment Market studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia.

Based on Distribution Channel, the Neuralgia Treatment Market studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Neuralgia Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neuralgia Treatment Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuralgia Treatment Market including Biogen Inc., Cadila Healthcare Limited, Cephalon Inc., GlaxoSmithKline PLC, GLENMARK PHARMS LTD., H. Lundbeck A/S, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., LGM Pharma LLC, Lupin Limited, Novartis AG, Pfizer Inc., Psychotropics India Limited, Takeda Pharmaceutical Company Limited, Teikoku Pharma USA, Inc., Teva Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., and UCB Group.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuralgia Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neuralgia Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuralgia Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuralgia Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Neuralgia Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Neuralgia Treatment Market?

6. What are the modes and strategic moves considered suitable for entering the Global Neuralgia Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Indication Outlook
  • 3.4. Distribution Channel Outlook
  • 3.5. Treatment Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of neuralgia due to the rise in the aging population
      • 5.1.1.2. Government initiatives to spread awareness regarding neuralgia treatment products
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost associated with the treatment of neuralgia
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement eliminates the need for drugs and surgery
      • 5.1.3.2. Developing surgical and pharmacological treatment in developing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Persistent side effects from medications
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Neuralgia Treatment Market, By Treatment Type

  • 6.1. Introduction
  • 6.2. Drug Based
    • 6.2.1. Anticonvulsant Medicines
    • 6.2.2. Tricyclic Antidepressants
  • 6.3. Surgery
    • 6.3.1. Balloon Compression
    • 6.3.2. Glycerol Injection
    • 6.3.3. Microvascular Decompression
    • 6.3.4. Radiofrequency Thermal Lesioning
    • 6.3.5. Stereotactic Radiosurgery

7. Global Neuralgia Treatment Market, By Indication

  • 7.1. Introduction
  • 7.2. Diabetic Neuropathy
  • 7.3. Intercostal Neuralgia
  • 7.4. Occipital Neuralgia
  • 7.5. Peripheral Neuralgia
  • 7.6. Postherpetic Neuralgia
  • 7.7. Trigeminal Neuralgia

8. Global Neuralgia Treatment Market, By Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Neuralgia Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neuralgia Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. South Korea
  • 10.10. Thailand

11. Europe, Middle East & Africa Neuralgia Treatment Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis
  • 12.4. Competitor SWOT Analysis
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Biogen Inc.
  • 13.2. Cadila Healthcare Limited
  • 13.3. Cephalon Inc.
  • 13.4. GlaxoSmithKline PLC
  • 13.5. GLENMARK PHARMS LTD.
  • 13.6. H. Lundbeck A/S
  • 13.7. Janssen Pharmaceuticals, Inc.
  • 13.8. Johnson & Johnson Services, Inc.
  • 13.9. LGM Pharma LLC
  • 13.10. Lupin Limited
  • 13.11. Novartis AG
  • 13.12. Pfizer Inc.
  • 13.13. Psychotropics India Limited
  • 13.14. Takeda Pharmaceutical Company Limited
  • 13.15. Teikoku Pharma USA, Inc.
  • 13.16. Teva Pharmaceuticals Ltd.
  • 13.17. Torrent Pharmaceuticals Ltd.
  • 13.18. UCB Group

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.